The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 15, 2025
Filed:
Oct. 08, 2024
Applicant:
Csl Innovation Pty Ltd, Melbourne, AU;
Inventors:
Lisa Margareta Lindqvist, Melbourne, AU;
Andreas Gille, King of Prussia, PA (US);
Paolo Rossato, Marburg, DE;
Markus Brechmann, Marburg, DE;
John Davis Belcher, Minneapolis, MN (US);
Gregory M. Vercellotti, Stillwater, MN (US);
Assignee:
CSL Innovation Pty Ltd, Melbourne, AU;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61P 7/06 (2006.01); A61P 9/10 (2006.01); A61K 35/18 (2015.01); C07K 14/535 (2006.01); C07K 14/715 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
A61K 39/3955 (2013.01); A61P 7/06 (2018.01); A61P 9/10 (2018.01); A61K 35/18 (2013.01); C07K 14/535 (2013.01); C07K 14/7153 (2013.01); C07K 16/2866 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/626 (2013.01); C07K 2317/76 (2013.01);
Abstract
The present disclosure relates to methods for treating or preventing or delaying progression or reducing or inhibiting or hindering development of a complication associated with sickle cell disease in a subject suffering from sickle cell disease, the method comprising administering to the subject a compound that inhibits granulocyte colony stimulating factor (G-CSF) signaling and/or G-CSF activity.